Achieve Life Sciences ACHV
NASDAQ ACHV
$7.24 -0.29 (-3.85%)
At close: Oct 2, 2026 · 4:00 PM EDT

Achieve Life Sciences (ACHV) Other Accumulated Expenses (2013 - 2026)

Updated

Achieve Life Sciences (ACHV) posted Other Accumulated Expenses of $1.1 million for Q2 2026, down 9.4% from $1.22 million a year earlier and down 52.8% from the prior quarter.

Analysis

Achieve Life Sciences (ACHV) Other Accumulated Expenses (2013 - 2026) Analysis & Trends

At the end of FY2025, Achieve Life Sciences' Other Accumulated Expenses came in at $604,000, up 5.4% from FY2024.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 0.7% (FY2020 to FY2025).
  • In prior years, Achieve Life Sciences' Other Accumulated Expenses was $573,000 in FY2024 (+63.2%), $351,000 in FY2023 (-12.9%), $403,000 in FY2022 (+15.8%) and $348,000 in FY2021 (-40.4%).
  • Quarterly Other Accumulated Expenses has run from a low of $194,000 in Q3 2021 to a high of $2.34 million in Q1 2026 over five years.
  • On a year-over-year basis, Other Accumulated Expenses increased in seven of the last eight quarters, with growth averaging 49.0%.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q1 2022, with growth of 207.1%; the weakest was Q3 2021, with a decline of 46.1%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $2.34 million (Q1 2026), $604,000 (Q4 2025) and $1.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Achieve Life Sciences 315.63 Mn 315.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Mar 31, 2026 2.34 Mn
Dec 31, 2025 604,000.00
Sep 30, 2025 1.80 Mn
Jun 30, 2025 1.22 Mn
Mar 31, 2025 1.30 Mn
Dec 31, 2024 573,000.00
Sep 30, 2024 898,000.00
Jun 30, 2024 617,000.00
Mar 31, 2024 1.04 Mn
Dec 31, 2023 351,000.00
Sep 30, 2023 693,000.00
Jun 30, 2023 752,000.00
Mar 31, 2023 699,000.00
Dec 31, 2022 403,000.00
Sep 30, 2022 539,000.00
Jun 30, 2022 513,000.00
Mar 31, 2022 648,000.00
Dec 31, 2021 348,000.00
Sep 30, 2021 194,000.00
API Access

Achieve Life Sciences Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ACHV&period=max&api_key=YOUR_API_KEY